Press Release
Applaud Medical Changes Name to Avvio Medical, Ushering in a New Era of Kidney Stone Treatment
July 16, 2024 | Press Release
San Francisco, California – Avvio Medical, Inc. (formerly Applaud Medical), a company dedicated to revolutionizing the treatment of urinary stones, today…
Favorable Clinical Data for Applaud Medical’s Novel Technology for Treating Urinary Stones Presented During the 2024 AUA Annual Meeting
May 6, 2024 | Press Release
San Francisco, California – Applaud Medical, an emerging leader in the treatment of urinary stones, today announced positive results from a…Applaud Medical Appoints Paul Molloy as Chief Executive Officer and a Member of the Company’s Board of Directors
January 11, 2023 | Press Release
SAN FRANCISCO--Applaud Medical, an emerging leader in the treatment of urinary stone disease, announced today the appointment of industry veteran…Applaud Medical Receives FDA Breakthrough Device Designation for the Company’s Acoustic Enhancer for Use in Conjunction With Ureteroscopy With Laser Lithotripsy (URS-LL) for the Fragmentation of Calcium-Based Kidney Stones
January 31, 2022 | Press Release
SAN FRANCISCO--Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced that its Acoustic Enhancer technology has…
CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use. Avvio Medical, Inc. does not currently offer medical devices for sale or distribution and the company’s technology has not received market clearance status by the U.S. FDA or any other country’s regulatory authority.
MKT-006 Revision O, April 2025.